Jessica B. Langbaum

Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

Eric M. Reiman, Kewei Chen, Xiaofen Liu et al. · Proceedings of the National Academy of Sciences · 2009 · 791 citations · Full text

Fibrillar Amyloid-β Burden, Neurochemical Biomarkers, Geriatric Neurology +21

Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study

Eric M. Reiman, Yakeel T. Quiroz, Adam Fleisher et al. · The Lancet Neurology · 2012 · 536 citations · Full text

Neuroimaging Biomarkers, Young Adults, Alzheimer's Disease +12

Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI)

Jessica B. Langbaum, Kewei Chen, Wendy Lee et al. · NeuroImage · 2009 · 275 citations · Full text

Positron Emission Tomography, Neuroimaging Biomarkers, Neurodegenerative Diseases +14

Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study

Adam Fleisher, Kewei Chen, Yakeel T. Quiroz et al. · The Lancet Neurology · 2012 · 226 citations

Neurodegenerative Diseases, Alzheimer's Disease, Florbetapir Pet Analysis +8

Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer's disease risk groups

Adam Fleisher, Ayesha Sherzai, Curtis Taylor et al. · NeuroImage · 2009 · 217 citations · Full text

Neuroimaging Biomarkers, Brain Function, Disease Risk Groups +12